Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Gil Klinger, deputy director1,
  2. Paul Merlob2
  1. 1Neonatal Intensive Care Unit, Schneider Children’s Medical Center of Israel, Petah Tiqwa, 49202, Israel
  2. 2Beilinson Teratology Information Service (BELTIS), Rabin Medical Center, Petah Tiqwa, 49100, Israel
  1. gilkl{at}post.tau.ac.il

    In a population study, Pedersen and colleagues found a twofold increased risk of septal heart defects after first trimester exposure to selective serotonin reuptake inhibitors (SSRIs).1 The prevalence increased with citalopram or sertraline but not paroxetine or fluoxetine, and exposure to more than one type of SSRI posed the greatest …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular